International Healthcare Executive, Georgina Rizik, to Lead London’s New Life Sciences Innovation District, SC1
Retrieved on:
Friday, June 24, 2022
Science, Biotechnology, Research, Pharmaceutical, Finance, Oncology, Health, Professional Services, Patient, Heart, Research, Marketing, Foundation, Industry, Organic, University, Roche, Clinical pharmacy, Life, MP, King's Health Partners, Student, Academic health science centre, Regeneration, Health equity, Innovation, MBA, Investment, Cabinet, Boehringer Ingelheim, Education, Creative, CEO, Novartis, Senior, Workforce, Health, NHS, List of life sciences, NHS foundation trust, SC1, Board, Royal Brompton Hospital, Hospital, King's College London, Royal Street, New Orleans, Imperial College London, Economic development, Management, Healthcare, Creative industries, Medicine, Ipsen, Biotechnology, Biotechnology, Pharmacy, Science
SC1, Londons new Life Sciences Innovation District being developed in south central London, UK, has announced the appointment of a new Executive Director, Georgina Rizik.
Key Points:
- SC1, Londons new Life Sciences Innovation District being developed in south central London, UK, has announced the appointment of a new Executive Director, Georgina Rizik.
- Georgina is a leading international healthcare and biotechnology commercial executive with over 25 years experience across private, public and non-profit organisations.
- Starting in June, Georgina will lead SC1, which was founded by Kings Health Partners, Guys & St Thomas Foundation, and Lambeth and Southwark councils.
- It is a privilege and honour to be the leader for SC1, Londons Life Sciences Innovation District.